Ophthalmologist Richard Lindstrom, MD, has been appointed to the board of directors of Ocular Therapeutix, according to a news release.
Founded in 2006, Ocular Therapeutix focuses on the development and commercialization of ophthalmic therapeutic products.
Dr. Lindstrom is founder of Minnesota Eye Consultants and serves as adjunct professor emeritus at University of Minnesota's department of ophthalmology.
"We are incredibly fortunate to have Dr. Lindstrom join our board of directors," said Amar Sawhney, president and CEO of Ocular Therapeutix, in the release. "As one of the top thought leaders in the industry, Dr. Lindstrom's input and guidance will be invaluable as we advance our sustained release drugs through clinical trials."
Ocular Therapeutix is headquartered in Bedford, Mass.
Related Articles on Ophthalmologists:
Ophthalmologist on the Move: Dr. Juan Javier Servat Joins CT's Yale Medical Group
Ophthalmologist Dr. Thomas Prater Receives Community Award
Ophthalmologist Dr. George Spaeth Receives Glaucoma Foundation Award